Work

Pro-Con: Antiobesity Drugs Such as Glucagon-Like Peptide-1 Receptor Agonists Should Be a First-Line Treatment in Idiopathic Intracranial Hypertension

Year: 2026

Type: article

Abstract: In this Pro-Con piece, our authors tackle the question of whether or not antiobesity drugs (glucagon-like peptide-1 receptor agonists) should be the new first-line treatment in Idiopathic Intracranial Hypertension (IIH).

Source: Journal of Neuro-Ophthalmology

DOI: 10.1097/wno.0000000000002431

Authors: Maria G. Lange, Aroucha Vickers, Lisa J. Hill, Susan P. Mollan, James Mitchell, Alexandra J. Sinclair, Andrew G. Lee

Institutions: Houston Methodist, University Hospitals Birmingham NHS Foundation Trust, Baylor College of Medicine, Valley Hospital Medical Center, National Institute for Health and Care Research, University of Birmingham

Language: English

Topic: Cerebral Venous Sinus Thrombosis

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: Sir Jules Thorn Charitable Trust

OpenAlex ID: W7129825658

FWCI:

Cites: 96

Cited by:

Related to: